Boulding Mark Elliott bought PTCT
September 12, 2025 · Form 4 insider transaction
Boulding Mark Elliott bought 22,661 shares of PTC Therapeutics, Inc. at $38.10 per share, a transaction worth $863.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,661
Price
$38.10
Total value
$863.4K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 12, 2025
Filing dateSeptember 15, 2025
Shares owned after126,562
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 5, 2024.